The importance of accurately characterizing lymphoproliferative disease
Foss, F.M.
Oncology 23(13): 1168; 1170
2009
ISSN/ISBN: 0890-9091 PMID: 20043467 Document Number: 634983
Document emailed within 1 workday
Related Documents
Ogun, G.O. 2015: Mesenchymal Tumours of the Gastrointestinal Tract: the Importance and use of Immunhistochemistry in Characterizing Specific Tumour Entities Nigerian Journal of Medicine: Journal of the National Association of Resident Doctors of Nigeria 24(2): 150-154Bulycheva, T.I.; Samoĭlova, R.S.; Sarkisian, G.P.; Novikova, M.S. 1995: The diagnostic and prognostic importance of immunophenotyping in hemoblastoses and chronic lymphoproliferative diseases Klinicheskaia Laboratornaia Diagnostika 6: 75-76
Fisher, J.G.; Kalb, B.; Martin, D.; Dhere, T.; Perez, S.D.; Srinivasan, J.K. 2015: Abdominal MRi without Enteral Contrast Accurately Detects Intestinal Fibrostenosis in Patients with Inflammatory Bowel Disease American Surgeon 81(11): 1118-1124
Beard, J.H. 2014: Characterizing the global burden of surgical disease: a method to estimate inguinal hernia epidemiology in Ghana: reply World Journal of Surgery 38(4): 999-1000
Załeska, J.; Chojak-Figura, E.; Lesiak, B. 1984: Pulmonary aspergillosis in lymphoproliferative disease Pneumonologia Polska 52(5): 257-263
Lewkonia, R.M.; Pineo, G.F. 1982: Angioedema-like skin lesions associated with lymphoproliferative disease Canadian Medical Association Journal 127(9): 867-868
Nalesnik, M.A. 1997: Posttransplant lymphoproliferative disease of donor origin Archives of Pathology and Laboratory Medicine 121(7): 665-666
Nichols, K.E. 2000: X-linked lymphoproliferative disease: genetics and biochemistry Reviews in Immunogenetics 2(2): 256-266
Herrmann, J.B. 1971: Lymphoproliferative disease secondary to breast cancer New York State Journal of Medicine 71(10): 1108-1111
Aisenberg, A.C.; Wilkes, B.M.; Long, J.C.; Harris, N.L. 1980: Cell surface phenotype in lymphoproliferative disease American Journal of Medicine 68(2): 206-213
Tangen, J.M. 1983: Toxoplasmosis and malignant lymphoproliferative disease. A case report Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 103(16): 1329-1330
Král, V.; Jílek, D.; Pajerek, J.; Stasný, J.; Kofer, J.; Vávra, M.; Richter, J. 1990: X chromosome-linked lymphoproliferative syndrome (Duncan's disease) Casopis Lekaru Ceskych 129(8): 247-251
Vahancík, A.; Babusíková, O.; Ujházy, P.; Klobusická, M.; Jakubovský, J.; Izakovic, V. 1988: Chronic lymphoproliferative disease of large granular lymphocytes Neoplasma 35(1): 81-89
Zambello, R.; Chisesi, T.; Agostini, C.; Trentin, L.; Masciarelli, M.; Gasparotto, G.; Vespignani, M.; Casorati, G.; Foa, R.; Semenzato, G. 1987: Cytotoxic in vitro function in the lymphoproliferative disease of granular lymphocytes Clinical and Experimental Immunology 70(1): 222-230
Longo, G.; Fiorani, C.; Bonacorsi, G.; Vanzanelli, P.; Sani, F.; Bevini, M.; Curci, G.; Torelli, U. 1992: Efficacy of erythropoietin in anemia of patients with immuno-lymphoproliferative disease Recenti Progressi in Medicina 83(7-8): 449-454
Pittoni, V.; Sorice, M.; Circella, A.; Cangemi, R.; Conti, L.; Ramenghi, U.; Gandolfo, G.M.; Dianzani, U.; Valesini, G. 2003: Specificity of antinuclear and antiphospholipid antibodies in sera of patients with autoimmune lymphoproliferative disease (ALD) Clinical and Experimental Rheumatology 21(3): 377-385
Franco, A.; Jiménez, L.; Aranda, I.; Alvarez, L.; González, M.; Rocamora, N.; Olivares, J. 2002: Diffuse lymphoproliferative disease after renal transplantation and its relation with Epstein-Barr virus. Experience at one center Nefrologia: Publicacion Oficial de la Sociedad Espanola Nefrologia 22(5): 463-469
Lioté, F.; Pertuiset, E.; Cochand-Priollet, B.; D'Agay, M.F.; Dombret, H.; Numéric, P.; D'Anglejan, G.; Kuntz, D. 1995: Methotrexate related B lymphoproliferative disease in a patient with rheumatoid arthritis. Role of Epstein-Barr virus infection Journal of Rheumatology 22(6): 1174-1178
Zambello, R.; Loughran, T.P.; Trentin, L.; Pontisso, P.; Battistella, L.; Raimondi, R.; Facco, M.; Sancetta, R.; Agostini, C.; Pizzolo, G. 1995: Serologic and molecular evidence for a possible pathogenetic role of viral infection in CD3-negative natural killer-type lymphoproliferative disease of granular lymphocytes Leukemia 9(7): 1207-1211
Hudnall, S.D.; Melez, K.; Galindo, A.; Bryson, Y. 1996: Massive pseudolymphomatous pericardial effusion in the posttransplant setting mimicking posttransplant lymphoproliferative disease Transplantation 61(12): 1776-1778